Keyphrases
Cardiovascular Disease
100%
Type 2 Diabetic Patients
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Cardiovascular Risk
33%
Second-line Therapy
33%
Head-to-head Comparison
22%
Myocardial Infarction
11%
Heart Failure
11%
Atrial Fibrillation
11%
Cardiovascular Outcomes
11%
Diabetes Therapy
11%
Low Risk
11%
Comorbidity
11%
Multivariable
11%
Cardiovascular Disease Events
11%
Incident Cardiovascular Disease
11%
Hazard Ratio
11%
Composite Outcome
11%
Therapy Initiation
11%
Up to Five
11%
MarketScan
11%
Propensity Score
11%
Protective Association
11%
Medicine and Dentistry
Cardiovascular Disease
100%
Patient with Type 2 Diabetes
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Apoplexy
11%
Diabetes
11%
Drug Therapy
11%
Atrial Fibrillation
11%
Population Research
11%
Myocardial Infarction
11%
Congestive Heart Failure
11%
Hazard Ratio
11%
Comorbidity
11%
Pharmacology, Toxicology and Pharmaceutical Science
Sodium Glucose Cotransporter 2 Inhibitor
100%
Cardiovascular Disease
100%
Non Insulin Dependent Diabetes Mellitus
100%
Population Study
11%
Heart Infarction
11%
Cerebrovascular Accident
11%
Congestive Heart Failure
11%
Atrial Fibrillation
11%
Comorbidity
11%